T-knife
Vida Farsam, PhD, serves as Associate Director and Head of Process Development at T-knife Therapeutics since February 2021, specializing in developing tumor-specific T cell receptor therapies for cancer. Prior experience includes a role as Senior Scientist at Max Delbrück Center from May 2017 to February 2021, where involvement centered on late-stage R&D for cell and gene therapies using innovative technologies, along with preclinical development of advanced therapy medicinal products. Earlier positions included Research Scientist at Institute of Clinical Transfusion Medicine and Immunogenetics and Doctoral Researcher at Universitätsklinikum Ulm, focusing on cancer research and HLA typing. Academic credentials include a PhD in Molecular Medicine from Ulm University and an MSc in Medical Immunology from Tarbiat Modares University.
This person is not in any teams
This person is not in any offices
T-knife
T-knife is a fast-growing, pre-clinical-stage biopharmaceutical company developing tumor-specific T cell receptor (TCR) therapies.